MKI67 and breast cancer: These studies, including the first reproducibility study of the Swiss Working Group of Gyneco- and Breast Pathologists, reported poor to fair agreement on Ki-67 LI assessment in midrange breast cancer, with Kappa values ranging from 0.04–0.36 [3, 8, 9, 11].